I looked at my father Jackie Chan in 1988

, I saw my father Jackie Chan in 1988

When talking about cooperation, the eyes of everyone present are very fiery.

Merck of course wants to get Ji Sheng's technology, and they are willing to spend more money.

But Ji Sheng definitely didn't want to kill the hen that lays golden eggs to get the eggs.

The two parties started business negotiations with their own different purposes.

As the head of Merck today, Dr. Roy Vagelos is naturally the first to speak in negotiations of this scale, "Mr. Ji, I am very optimistic about this hepatitis B vaccine technology, but I don't know you What do you think, and what benefits do you want to gain from Merck with this technology? In this way, you can talk about your thoughts first, and let me hear if it’s okay.”

"Yes, tell me what you think first."

"As long as you have the sincerity to hand over this technology to Merck, everything is negotiable."

People like Alison Horne and Liam Jack said so.

Joshua Borg stopped talking at this moment, and his task of accompanying Ji Sheng Qianlai was basically completed.

However, Ji Sheng glanced at Joshua Borg before saying, "First of all, I want to express my opinion, that is, I will not sell the patent right of this technology."

There was a burst of disappointment in Mason Landy's eyes.

Roy Vagelos and others also knew that Ji Sheng would say this, and they were mentally prepared, but after they really heard it, they couldn't help but smiled bitterly. They really wanted to win this technology.

"Then how do you want to cooperate?" Roy Vagelos asked.

Ji Sheng said clearly: "I have two plans."

Roy Vagelos stretched out his hand and said, "Please speak."

Ji Sheng hummed, "The first plan is a super-long authorization period. I hope to sign a patent authorization with Merck for more than 20 years. The annual authorization fee is no less than 20.00 million U.S. dollars, and I still need to take 20% Five of the pure profit sharing, I will only authorize this authorization to Merck in the beautiful country, that is, no other company will compete with Merck for the market share of hepatitis B vaccine in the beautiful country because of this technology, as for other countries in the world, I will It will still authorize. Whether Merck can do better than other companies will depend on its own strength. In addition, because of some special reasons, if your company chooses this plan, I need Merck to give you a [-]-year authorization at once. fee, and give me at least one billion today, and the remaining one billion can be made up slowly."

He said that this plan is tantamount to saying nothing.

As long as it is an individual, it will not agree.

It’s not that the annual licensing fee of 20.00 million US dollars is expensive, nor is it that the requirement of 20% five-year pure profit sharing is too much, but that the [-]-year licensing fee is given at once, and no one is happy to change it. How soon, if there is a more advanced hepatitis B vaccine technology than Ji Sheng's in the future, then Merck will have to lose money?

While the odds are low, it's not impossible.

However, to Ji Sheng's surprise, Roy Vagelos simply raised his head and said without hesitation after discussing with the Merck executives present: "I think this plan is okay."

Ji Sheng: "..."

Joshua Berger: "..."

They didn't expect Roy Vagelos to agree so simply, and they were a little dumbfounded.

Roy Vagelos is not a fool, of course he agreed to Ji Sheng's request.

First of all, although Ji Sheng did not say exclusive authorization, he just promised that the beautiful country will not authorize other companies, but as long as Merck agrees, it will be easy to quickly seize the global market share with its own strong strength. After all, Merck The original old ones are there, and after discussing with customers, the old ones can be replaced with vaccines produced by new technologies.

At that time, even if other countries in the world have obtained the authorization, they will still not be able to compete with Merck in the market competition.

This is one reason.

Another very important reason is that even if no one knows how fast the development of medical technology will be in the future, Merck, as the world's largest pharmaceutical company, can analyze and conclude that it wants to develop the technology that Bi Jisheng brought. This hepatitis B vaccine technology is more advanced technology, at least not less than ten years.

Why is Merck so sure?

It’s very simple. Normally, it takes six to seven years to develop a new drug. This is still the average time. Some drugs even take more than ten years to develop. Let’s not mention this for now. Even if someone only spends six to seven years developing a new technology , It is also impossible to go on the market directly, and there are many links to go through. That is to say, it will take at least ten years from the development of a new drug to its successful launch, and the average research and development funds spent are not less than 26 billion US dollars.

This number was summed up by countless people in Merck and the pharmaceutical industry, and basically the difference will not be too big.

If Merck gets this technology, how much money can it make in ten years?

In the past two years, Merck earned 120 billion US dollars with their self-developed hepatitis B vaccine technology, an average of 60 billion per year. This is still on the premise that there is a competitor, Smith Kline. Coupled with their original market share and production line, they can easily overtake SmithKline in the hepatitis B vaccine market share, and may even reach a net profit of more than 100 billion US dollars per year!

Even if Ji Sheng is given a 20.00% share of the five pure profits, it will be more than what they are currently earning.

This is one of the advantages. Another advantage is that sales are often bundled. While Merck develops more market share with this new technology, it will drive the sales of other drugs of the company, and the profits will be immeasurable at that time. , rising geometrically!

With so many benefits, do Roy Vagelos and other senior executives at Merck still need to hesitate?

Of course without any hesitation!

Merck is determined to win this technology.

But Ji Sheng didn't think so. The first plan he gave was simply to let Merck have a choice, or in other words, on the premise of not agreeing to the second request, he could leave a hopeful one for himself. Get your money back today.

He thought about it and said quickly: "Don't agree so quickly, why don't you listen to my second plan?"

"Need not."

"The first plan is very good."

"Well, we are willing to spend money to buy this technology license."

Merck's top brass have deep pockets.

Ji Sheng fainted.

Fortunately, Roy Vagelos reached out his hand to stop everyone from continuing. He nodded slightly and said: "There is no loss in listening to the second plan, Mr. Ji, let's talk."

Only then did Ji Sheng heave a sigh of relief, and said surprisingly: "The second plan, I don't want the authorization fee!"

"What?" Mason Randy looked at Ji Sheng in astonishment.

Alison Horne's eyes widened all of a sudden.

Even Joshua Borg couldn't help showing an expression of disbelief.Obviously, no one knows why Ji Shengming has such a technology that can earn high licensing fees, so why does he say no licensing fees.

Roy Vagelos said blankly: "You don't want the authorization fee?"

"To put it simply, I don't want a direct licensing fee, I only take a share of the pure profit. Of course, I have to add a condition." Ji Sheng said in a different tone.

Roy Vagelos couldn't wait to ask: "Be more careful."

Ji Sheng said: "My idea is to take 30.00% of the net profit share, plus you Merck lent me a billion dollars."

With only a 5.00% increase in the pure profit share, it can save [-] million US dollars in licensing fees every year!

If calculated in terms of net profit, Merck would have to earn an additional US$20 billion a year on the hepatitis B vaccine before it could lose money. It seems that the second proposal proposed by Ji Sheng is even more exciting.

So, Ji Sheng is really so kind that he doesn't want the licensing fee of 20 million U.S. dollars per year, so can he earn [-] billion more every year by going to Bomerk?The answer is definitely not, because he knows that as the global economy is getting better and better, countries will seek more and more hepatitis B vaccines. Maybe he will earn less because of this in the past few years, but in a few years, his first The second plan will make more money, and more importantly, the second plan does not need to be exclusively authorized in the United States. At that time, Ji Sheng can authorize Futai Pharmaceutical to sell in the beautiful country as well.

Even if Merck can quickly launch drugs to seize the market, Futai Pharmaceutical will definitely be favored by capital because it also has such technology. With the rapid financing and listing, Ji Sheng can cash out a part of the capital, and don't need to continue to spend money on support, so he can make a lot of money.

So Ji Sheng hoped that Merck would choose the second option he proposed.

Merck's senior executives were indeed conquered by the second plan.

The only thing that puzzled Roy Vagelos and the rest of Merck's top brass was the billion figure.

Want to borrow a billion dollars at once?Could it be that there is a problem with the core point of this technology, so this guy wants to take a billion and run away?

Roy Vagelos and Alison Horn and other senior executives at Merck have this idea.

But when they were puzzled, Ji Sheng took the initiative to say: "As long as you agree, we can sign the contract immediately, and I have brought the complete technical information, and you can verify on the spot whether it is true and effective. If it is If not, you can lend me one billion dollars. If not, you can cancel the contract immediately, and I only need two months for this loan. We can even add a clause in the contract. If I don’t return the ten million dollars after two months Billion dollars, the patent right of this technology was transferred to Merck, exactly two months, enough time for you to produce the first batch of vaccines to seize the market.”

After signing the contract, the technology can be verified. If the technology is incomplete, they can cancel the contract. The most important thing is that if Ji Sheng fails to return the billion after two months, the technology patent will belong to Merck!

Now the top executives on Merck's side can't sit still.

"Roy, promise Mr. Ji."

"He has said so much, we have no reason not to agree."

"Yeah, first of all, we have to verify the technology before the contract will really come into effect. Secondly, if he returns less than one billion dollars in two months, the technology will belong to us. Let's agree."

Mason Randy, Liam Jack and others gasped and said that they all wanted to take this technology as their own right away.

But to everyone's surprise, Dr. Roy Vagelos frowned and asked: "Mr. Ji, I have heard continuously that you are going to get one billion dollars today. Excuse me, do you have any money?" Do you need money urgently?"

Alison Horne and the others reacted instantly.

Yes.

You have repeatedly stated that you want to get a billion dollars today, do you need money urgently?

If you need money urgently, you can lower the price.

high!

He is still the chairman!

Mason Landy and the others were in admiration.

Ji Sheng already knew that Dr. Roy Vagelos would ask, and he didn't hide anything: "Yes, I have an important investment that urgently needs a billion dollars in turnover, and if it goes well, the profit may reach more than [-]%! "

Mason Landy: "..."

Alison Horne: "..."

Liam Jack and others: "..."

They all sounded a little silly, borrowing a billion dollars to invest, and the profit reached more than [-]%?Doesn't that mean that you can earn a billion with a guarantee?This group of people couldn't help but want to ask Ji Sheng what to invest in, and then invest accordingly.

Of course, this was just everyone's first thought, and then the second thought came out, since you need money urgently, why don't we lower the price?

Roy Vagelos ignored the winks from his colleagues and continued to ask: "May I ask what kind of investment it is?"

Ji Sheng said honestly: "I am optimistic that the US dollar will continue to rise in the foreign exchange market, and I want to invest in US dollars in the foreign exchange market."

When everyone heard this, everyone was discouraged, and the idea of ​​​​following investment disappeared instantly.

why?

Because the U.S. dollar has been disturbed by various countries in recent years, it is impossible to rise sharply, and it has even fallen back a lot since April. Investing in U.S. dollars in the foreign exchange market is not throwing money into the water?

Just when everyone was full of thoughts, Dr. Roy Vagelos spoke again, "That's it, I agree."

what?

Don't lower the price?

Merck's top management was a little confused.

How did they know that Roy Vagelos was more than they thought. Since Ji Sheng wanted to invest in US dollars in the foreign exchange market, he would most likely lose money due to the "depression" of the US dollar in recent years.

What will happen next once Ji Sheng loses all his money in the foreign exchange market?

Needless to say, the billion dollars will definitely not come up. By then, the latest hepatitis B vaccine technology will belong to Merck?

Anyone is happy to buy a technology that can earn tens of billions or even hundreds of billions of dollars for a billion dollars.

To put it another way, let's not talk about how much money this technology can make in the future, just say that if Merck develops it by itself and it goes well, it will need to spend more than 20 billion.

Why didn't Roy Vagelos agree to the opportunity to use one billion dollars to buy technological research and development achievements worth at least more than 20 billion?This is much more cost-effective than lowering the price to get a license. The premise is to verify that the technology is indeed effective. After all, if it is invalid, Merck will not give Ji Sheng money.

Since this proposal was harmless to Merck, Roy Vagelos couldn't think of any reason to refuse, so he agreed to lend Ji Sheng one billion.

Ji Sheng had no idea that Roy Vagelos had this idea at all, but when he heard that the other party was willing to take a billion dollars, he suddenly became excited, got it, finally got the money, he can trade in the foreign exchange market Stretch your muscles and make more money!

Although the future benefits of the hepatitis B vaccine were sacrificed, if Ji Sheng can earn more money now, he can quickly earn ten times more than the future benefits of the hepatitis B vaccine by combining the money with the information collected in modern society. Ten times or even a hundred times the money, what he lacks is not a way to get rich, but a lack of money to develop rapidly!